$SCMP Sucampo Pharmaceuticals, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sucampo Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Sucampo Pharmaceuticals, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Sucampo Pharmaceuticals, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Alder Matthias | EVP, Gen. Council & Sec. | 4,763 | 54,060 | Jul 07 2017 | |||
| Ashton William | Director | 0 | 0 | Mar 18 2015 | |||
| Ashton William | Director | 0 | 0 | Jun 05 2012 | |||
| Ashton William | Director | 0 | 0 | Jun 09 2014 | |||
| Astellas Pharma Inc. | 1,253,750 | 14,230,063 | Aug 08 2007 | ||||
| Bryan Jones W. | Sr. Vice Pres., BD & Licensing | 5,139 | 58,328 | Jan 12 2018 | |||
| Celeste Anthony C. | Director | 0 | 0 | Mar 18 2015 | |||
| Celeste Anthony C. | Director | 5,000 | 56,750 | Oct 14 2009 | |||
| Celeste Anthony C. | Director | 0 | 0 | Jun 05 2012 | |||
| Celeste Anthony C. | Director | 0 | 0 | May 30 2013 | |||
| Celeste Anthony C. | Director | 68,800 | 780,880 | Jun 09 2014 | |||
| Claiborne Cary J | Chief financial officer | 1,938 | 21,996 | Oct 01 2013 | |||
| Claiborne Cary J | Chief Financial Officer | 2,864 | 32,506 | Dec 17 2014 | |||
| Dolecek Gayle R | SVP Research & Development | 0 | 0 | Dec 19 2007 | |||
| Dolecek Gayle R | VP of Research & Development | 0 | 0 | Jan 26 2010 | |||
| Dolecek Gayle R | VP of Research and Development | 0 | 0 | May 16 2011 | |||
| Dolecek Gayle R | Director | 0 | 0 | Mar 21 2014 | |||
| Donley Matthew Maxwell | EVP, Global HR, IT & Strategy | 36,975 | 419,666 | Jan 04 2018 | |||
| Driggs Alex | General Counsel & Corp. Sec. | 0 | 0 | Feb 13 2018 | |||
| Edick Paul R | Director | 14,930 | 169,456 | Jun 05 2017 | |||
| Egan James | Chief Operating Officer | 0 | 0 | Sep 28 2009 | |||
| Egan James | Director | 0 | 0 | May 04 2011 | |||
| Fackler Brad E | EVP Commercial Operations | 0 | 0 | Dec 19 2007 | |||
| FERRARA ANDREW J | Director | 0 | 0 | Oct 14 2009 | |||
| FERRARA ANDREW J | Director | 0 | 0 | May 04 2011 | |||
| Getman Daniel P | Director | 16,201 | 183,881 | Nov 30 2016 | |||
| Getman Daniel P | Director | 0 | 0 | Jun 09 2014 | |||
| Greenleaf Peter | Chief Executive Officer | 4,792 | 54,389 | Jan 04 2018 | |||
| Greenleaf Peter | Chief Executive Officer | 0 | 0 | Aug 04 2014 | |||
| Greenleaf Peter | Chief Executive Officer | 0 | 0 | Sep 15 2014 | |||
| JOHNSON JOHN | Director | 0 | 0 | Dec 15 2014 | |||
| Johnson John H | Director | 0 | 0 | Feb 13 2018 | |||
| KAISER RONALD W | CFO | 0 | 0 | Dec 19 2007 | |||
| Kiener Peter A | Chief Science Officer | 0 | 0 | Feb 13 2018 | |||
| Knapp Thomas J | EVP, Chief Legal Ofc, Corp Sec | 0 | 0 | Jul 22 2015 | |||
| Knapp Thomas J | Director | 0 | 0 | May 04 2011 | |||
| Knapp Thomas J c/o Sucampo Pharmaceuticals, Inc. | EVP, Chief Legal Ofc, Corp Sec | 0 | 0 | Sep 15 2014 | |||
| Kuno Sachiko | 10% Owner | 7,137,344 | 81,008,854 | Sep 13 2017 | |||
| Kuno Sachiko | 10% Owner | 22,460,802 | 254,930,103 | Aug 07 2014 | |||
| Lichtlen Peter | Chief Medical Officer | 24,000 | 272,400 | Mar 08 2017 | |||
| MAUDLIN TIMOTHY I | Director | 32,870 | 373,075 | Jun 05 2013 | |||
| MAUDLIN TIMOTHY I | Director | 0 | 0 | Oct 14 2009 | |||
| MAUDLIN TIMOTHY I | Director | 0 | 0 | Jun 05 2012 | |||
| Meyenburg Jason Patrick | Chief Commercial Officer | 0 | 0 | Feb 13 2018 | |||
| Miele Stanley G | Chief Commercial Officer | 93 | 1,056 | Nov 20 2015 | |||
| Miele Stanley G | Director | 0 | 0 | May 04 2011 | |||
| Miele Stanley G | SVP, Sales and Marketing | 223,200 | 2,533,320 | May 21 2013 | |||
| Miele Stanley G | President | 173,400 | 1,968,090 | Sep 15 2014 | |||
| Mine Hidetoshi | Director | 783,700 | 8,894,995 | Aug 07 2007 | |||
| Morris Mariam E | Chief Acctg. Officer, Treas. | 0 | 0 | Dec 19 2007 | |||
| MUNDER BARBARA A | Director | 0 | 0 | Jun 02 2015 | |||
| MUNDER BARBARA A | Director | 0 | 0 | May 30 2013 | |||
| MUNDER BARBARA A | Director | 0 | 0 | Jun 09 2014 | |||
| Nantahala Capital Management, LLC | 10% Owner | 97,788 | 1,109,894 | Apr 24 2012 | |||
| OCONNELL MAUREEN | Director | 0 | 0 | Feb 13 2018 | |||
| OCONNELL MAUREEN | Director | 0 | 0 | May 30 2013 | |||
| OCONNELL MAUREEN | Director | 0 | 0 | Jun 10 2014 | |||
| PFREUNDSCHUH PETER P. | CFO | 0 | 0 | Feb 13 2018 | |||
| R-Tech Ueno, Ltd. | 10% Owner | 2,485,150 | 28,206,453 | Aug 07 2007 | |||
| Ridgeway Capital Partners LTD | 10% Owner | 783,700 | 8,894,995 | Aug 07 2007 | |||
| S&R Technology Holdings, LLC | 10% Owner | 0 | 0 | Dec 21 2016 | |||
| S&R Technology Holdings, LLC | 10% Owner | 26,362,352 | 299,212,695 | Oct 03 2012 | |||
| S&R Technology Holdings, LLC | 10% Owner | 22,460,802 | 254,930,103 | Aug 07 2014 | |||
| Smilek Jan | Chief Accounting Officer | 0 | 0 | May 04 2010 | |||
| Smith Andrew P | Chief Financial Officer | 491 | 5,573 | Jan 06 2017 | |||
| Smith Karen L. | Director | 0 | 0 | Feb 13 2018 | |||
| Spiegel Robert J. | Director | 0 | 0 | Feb 13 2018 | |||
| Spiegel Robert J. | Director | 0 | 0 | Jan 26 2015 | |||
| Tolliver Kei S | Director | 0 | 0 | Jun 02 2015 | |||
| Tolliver Kei S | Director | 0 | 0 | May 30 2013 | |||
| Ueno Ryuji | 10% Owner | 8,006,585 | 90,874,740 | Sep 13 2017 | |||
| Walbert Timothy P | Director | 14,930 | 169,456 | Jun 05 2017 |